Summary:
Are you or a loved one currently being treated with buprenorphine medications such as Suboxone, Subutex, Bunavail, or Zubsolv for opioid dependence? Would you like to transition from buprenorphine medication to a non-opioid injectable naltrexone medication that is taken monthly?
The Segal Institute for Clinical Research is currently conducting a clinical research study evaluating the safety and efficacy of an investigation medication for patients with opioid use disorder.
Qualified Participants Must:
• Be between 18 and 60 years of age
•
Have been diagnosed with opioid use disorder for at least 6 months
•
Be currently taking Buprenorphine (SUBOXNE, SUBUTEX, BUNAVAIL, or ZUBSOLV)
Qualified Participants May Receive:
All study related exams, lab work and investigational study medication at no cost.
Complimentary transportation.
Compensation up to $1,850 for time and travel.